Revolution Medicines, Inc. (RVMD): Form 8-K filed 2026-10-13
- Accepted by EDGAR
- 2026-10-13 16:32 ET
- Event date
- 2026-10-08
- Accession no.
- 0001628171-26-000004
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The company became obligated under a material direct financial obligation, such as a loan, notes offering or credit facility draw, or under a material off-balance sheet arrangement. - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | rvmd-20261008.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.